Investor · Cambridge, MA
Alan Ezekowitz
Open Alan in the network graph →Filings
18
SEC Form D
Connections
90
co-filers
Capital
$163.8M
across filings
Active
Nov 2011
to Oct 2025
Most-connected co-filers (90)
Steven Altschuler · New York, NY12 sharedJordan P. Katz · SANTA MONICA, CA5 sharedTimothy P. Meyer · SANTA MONICA, CA5 sharedJeremy Tryba · Seattle, WA5 sharedSusan V. Rosenbaum · Little Rock, AR5 sharedStephen Klein · Miami Beach, FL5 sharedSteven C. Etchison · Little Rock, AR5 sharedSteve Altschuler · Watertown, MA5 sharedMatt Auriemma · Grand Cayman, Cayman Islands5 sharedNick Seaver · Watertown, MA4 sharedAndrew Bellinger · Watertown, MA4 sharedJonathan Kagan · Watertown, MA4 sharedP. H. Spaht · SAN FRANCISCO, CA3 sharedGayatri Sarkar · Boston, MA3 sharedSamantha A. Lomow · Pawtucket, RI3 sharedCarl D. Thoma · CHICAGO, IL3 sharedRyan K. Hart · Denver, CO3 sharedLee M. Mitchell · CHICAGO, IL3 sharedSamuel S. Crabill · SAN FRANCISCO, CA3 sharedSeth J. Boro · SAN FRANCISCO, CA3 sharedStephanie Weichsel · Brooklyn, NY3 sharedCarmen A. Bauza · Tampa, FL3 sharedOrlando M. Bravo · SAN FRANCISCO, CA3 sharedJames B. Hart, Jr · Denver, CO3 shared
Recent filings (18)
Corner Therapeutics, Inc.Oct 2025 · 15 co-filers$16.8MCorner Therapeutics, Inc.Oct 2025 · 15 co-filers$16.8MCorner Therapeutics, Inc.Aug 2025 · 23 co-filers$63.5MCorner Therapeutics, Inc.Aug 2025 · 23 co-filers$63.5MCorner Therapeutics, Inc.Apr 2025 · 23 co-filers$53.7MCorner Therapeutics, Inc.Apr 2025 · 23 co-filers$53.7MLYNK Capital Opportunity Fund, L.P.Jul 2024 · 16 co-filersLYNK Capital Fund, L.P.May 2024 · 16 co-filersCorner Therapeutics, Inc.Apr 2024 · 16 co-filers$50.9MCorner Therapeutics, Inc.Apr 2024 · 16 co-filers$50.9MSepterna, Inc.Jul 2023 · 15 co-filers$150.0MSepterna, Inc.Jul 2023 · 15 co-filers$150.0MAEP GALAXY-A, L.P.Jun 2023 · 5 co-filersAEP GALAXY, L.P.Jun 2023 · 5 co-filersANGELES EQUITY PARTNERS II, L.P.Dec 2022 · 5 co-filers$500.0MANGELES EQUITY PARTNERS II-A, L.P.Dec 2022 · 5 co-filers$500.0MThoma Bravo Credit Fund III Feeder B, L.P.Dec 2022 · 19 co-filers$1.8BThoma Bravo Credit Fund III Feeder A, L.P.Dec 2022 · 19 co-filers$1.8BThoma Bravo Credit Fund III Feeder, L.P.Dec 2022 · 19 co-filers$1.8BANGELES EQUITY PARTNERS II-EXEC, L.P.Nov 2022 · 5 co-filersFulcrum Therapeutics, Inc.Jun 2020 · 26 co-filers$68.5MFulcrum Therapeutics, Inc.May 2017 · 13 co-filers$5.0MAbide Therapeutics, Inc.Nov 2011 · 6 co-filers$2.3MAbide Therapeutics, Inc.Nov 2011 · 6 co-filers$2.3M
Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Alan in the interactive graph →